Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A New Study Evaluating the Activity of Modular CAR T for mYeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- NA
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
DARA RVD For High Risk SMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- Status
- RECRUITING
- Phase
- PHASE1
Expanded Access Protocol (EAP) for Participants Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release
- Status
- AVAILABLE
- Phase
- N/A
The TOTOM Trial: Tai Chi to Optimize Transplant Outcomes for Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
- Status
- UNKNOWN
- Phase
- N/A
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the My Hematology Oncology Patient Experience (MyHOPE™) For Multiple Myeloma (MM) Digital Care Network in Patients With MM
- Status
- TERMINATED
- Phase
- PHASE1
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
- Status
- UNKNOWN
- Phase
- N/A